NB Hot Topics Podcast cover image

S6 E12: Anti-Ds for Insomnia; SSRIs & Hypotension; Cancer Cures

NB Hot Topics Podcast

00:00

Promising Advances in Cancer Treatment with Dostalimab

This chapter explores a groundbreaking trial of dostalimab for patients with solid tumors that have mismatch repair deficiency, showcasing an impressive 84% complete clinical response rate. With a favorable side effect profile and high recurrence-free survival, the findings suggest a transformative shift in cancer treatment protocols.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app